Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.4 EUR | +2.75% |
|
+9.02% | +50.22% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+50.22% | 2.31B | - | ||
-5.31% | 181B | C+ | ||
-5.38% | 99.95B | C | ||
-6.04% | 66.21B | A | ||
+16.45% | 45.4B | B+ | ||
-8.08% | 45.36B | B- | ||
+8.38% | 43.84B | B- | ||
+12.06% | 29.03B | B | ||
+17.98% | 25.64B | A- | ||
-8.28% | 23.53B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- STAA Stock
- SR3 Stock
- Ratings STAAR Surgical Company